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Abstract 9 
In this study, the surface of a microporous walled micro-capillary film (MMCF) was 10 
modified into a weak anion exchanger by coupling cyanuric chloride and 2-11 
diethylaminoethylamine (DEAE) to the ethylene-vinyl alcohol (EVOH) matrix. Fourier 12 
transform infrared spectroscopy (FTIR) measurements of modified and unmodified MMCFs 13 
confirmed the addition of a triazine ring and DEAE onto the membrane. Binding of bovine 14 
serum albumin (BSA) at pH 7.2 was found to follow a Langmuir isotherm with a maximum 15 
equilibrium binding of 12.4 mg BSA/mL adsorbent and 8.2 mg BSA/mL adsorbent under 16 
static and flow conditions, respectively. The ion exchange capacity, determined by Mohr’s 17 
titration of chlorine atoms displaced from the functionalised surface, was found to be 195 ± 18 
21 μmol Cl- /mL of adsorber, comparable to commercial ion exchangers. BSA adsorption 19 
onto the ion exchanger was strongly pH-dependant, with an observed reduction in binding 20 
above pH 8.2. 21 
Frontal experiments of a BSA (5 mg/mL) and lysozyme (5 mg/mL) mixture demonstrated 22 
successful separation of BSA from lysozyme at more than 97% purity as verified by sodium 23 
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). Separation between 24 
similarly charged anionic molecules was also achieved using BSA (5 mg/mL) and herring 25 
sperm DNA (0.25 mg/mL). BSA was extracted at 100% purity, demonstrating the ability of 26 
MMCF-DEAE to remove significant DNA contamination from a protein solution. These 27 
experiments highlight the potential for MMCFs to be used for fast protein purification in 28 
preparative chromatography application. 29 
Key words: weak anion-exchange, chromatography, micro-capillary films, membranes, 30 
DEAE 31 
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1.  32 
Introduction 33 
The pharmaceutical industry has progressively shifted its focus from small chemical drugs 34 
towards the use of large biomolecules such as antibodies. In order to scale-up the 35 
manufacture of biopharmaceuticals and produce them at a greater efficiency, product-specific 36 
titres have increased steadily over the past three decades from less than 0.5 g/L in the early 37 
1990s to values in excess of 3 g/L for newer processes, with 7 g/L and above being the new 38 
top-end industry target [1]. This order of magnitude increase has moved the production 39 
bottleneck downstream, towards the product purification stage where technologies with 40 
greater throughput and faster separation capabilities are needed. 41 
Membranes have been demonstrated to be viable chromatography support for rapid protein 42 
purification on account of the high superficial velocities that can be attained without 43 
performance penalties [2]. As convective mass transport is the dominant mode by which 44 
separations occur, flowrate independent binding can be achieved. Membranes have been used 45 
in a wide range of chromatographic operations such as the purification of plasmid DNA using 46 
anion exchange [3], the capture of IgG using Protein A affinity chromatography [4] and the 47 
purification of retroviruses [5]. Membrane adsorbers still suffer from several disadvantages 48 
with respect to packed beds including their historically poor binding capacity [6] which limit 49 
their use in industry. 50 
Micro-capillary films (MCFs) aim to provide a low-cost technology for protein separations 51 
[7]. Composed of a continuous capillary array embedded into an ethylene-vinyl alcohol 52 
(EVOH) film matrix, these membranes have the potential for use in direct capture of proteins 53 
from unfiltered cell lysate. MCFs can be extruded as a non-porous (NMCFs) film using melt 54 
extrusion [8] or a porous (MMCFs) film using non-solvent induced phase separation (NIPS) 55 
[9]. Benefits of this technology include its ease of manufacture and scale-up (tubular 56 
configuration), its low cost (~ 50 pence/metre for MCF manufacture) [7] and the high 57 
superficial velocities through the membrane lumen which can be attained (greater than 5000 58 
cm/h) [10]. Moreover, the hydroxyl-rich nature of the polymer allows for a wide-range of 59 
ligands to be coupled to MCFs for chromatography applications. Q-functionalised MCFs 60 
have been successfully used to remove lentivirus from unfiltered culture media containing 61 
suspended solids [11] and strong cation SP- membranes have been used to separate 62 
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cytochrome-c and lysozyme [7], lysozyme from BSA [10] and to monitor at-line IgG 63 
aggregates in bioreactors [12].  64 
The objective of this paper was to develop and demonstrate a weak MMCF ion exchanger to 65 
complement existing MMCF chemistries. The MMCF was modified with 2-66 
diethylethylenediamine (DEAE) and the performance of the exchanger was characterised.   67 
The separation of BSA from lysozyme was used to determine the ability of MMCFs to 68 
separate model proteins of opposite charge at pH 7.2 and, the separation of BSA from herring 69 
sperm DNA was performed to highlight the potential use of MMCF-DEAE for residual DNA 70 
clearance. 71 
2.  72 
Materials and methods 73 
2.1  74 
Chemicals used 75 
Ethylene vinyl alcohol (EVOH) copolymer with 68 mol% vinyl alcohol was purchased from 76 
Kuraray (Hattersheim, Germany). N-methyl-2-pyrrolidine (NMP), polyvinyl-pyrrolidone 77 
(PVP, average molecular weight 360 kDa), glycerol, bovine serum albumin (BSA, pI 5.3, 78 
MW 66.4 kDa), tris(hydroxy- methyl)aminomethane (Tris), hydrochloric acid (HCl), sodium 79 
hydroxide (NaOH), sodium chloride (NaCl), crystalline chick-egg lysozyme (pI 11, MW 14.3 80 
kDa), sodium phosphate monobasic (NaH2PO4), 2-diethylaminoethylamine (DEAE), 81 
Bradford reagent and cyanuric chloride were purchased from Sigma Aldrich (St. Louis, MO, 82 
USA).  83 
2.2  84 
Membrane manufacture 85 
MMCFs were produced using protocols described previously [9] [10]. Briefly, polymer 86 
solutions containing 15/10/75 wt.% EVOH/PVP/NMP were wet extruded through a 19-87 
nozzle die of capillary size 0.5 mm, followed by non-solvent induced phase separation 88 
(NIPS) in a water bath. Membranes were then stored in a 50/50 v/v glycerol-water solution 89 
for long term processing. 90 
Gravimetric analysis was used to determine the column volume (CV) of the membranes so 91 
that the binding capacities obtained could be normalised and compared with commercial 92 
columns. The column volume, was defined as the total volume from the microporous walls 93 
and central capillaries of the film and was found to be 1.06 ± 0.09 mL for a 20 cm MMCF 94 
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section (dried weight, 164 ± 5 mg). A 20 cm MMCF length was used for this work as it had a 95 
convenient column volume ~ 1 mL. 96 
2.3  97 
BET and mercury intrusion porosimetry 98 
N2 adsorption was measured at 77.4 K using a Micromeritics ASAP 2020 instrument 99 
(Norcross, GA, USA) to determine the membrane surface area using Brunaeur-Emmett-Teller 100 
(BET) theory. The membrane pore surface area and pore size distribution (PSD) was 101 
measured using a Micromeritics AutoPore IV 9500 porosimeter (Norcross, GA, USA) up to a 102 
final pressure of 2000 bar. 103 
MMCF samples were vacuum dried overnight at 150°C prior to N2 adsorption and 104 
porosimetry measurements. 105 
2.4  106 
Chemical modification of MMCFs with DEAE 107 
The coupling of 2-diethylaminoethylamine (DEAE) onto the MMCF backbone was achieved 108 
using a modified batch protocol from McCreath et al. [13]. Briefly, a MilliQ washed 109 
membrane (25 cm, dry weight 205 ± 6 mg) was placed in 50 mM ice cold cyanuric chloride 110 
in acetone (40 mL) solution under constant agitation for 30 minutes. DEAE (2.48 g, 0.02 111 
moles) was added to a 0.5 M NaH2PO4 aqueous solution (36 mL), the final solution was at 112 
pH 9.6. Cyanuric chloride activated MMCF was added to the DEAE solution, heated 113 
overnight at 40°C then at 60°C for 5 hours. The membrane was subsequently washed with 114 
MilliQ (50 mL) for 30 minutes and reactivated with 0.5 M NaOH (40 mL) for 30 minutes. 115 
The chemical modification is summarised in Fig. 1. 116 
2.5  117 
Fourier transform infrared spectroscopy of MMCFs 118 
Fourier transform infrared spectroscopy (FTIR) was used to determine the presence of a 119 
cyanuric chloride ring and DEAE on the MMCF membrane. Spectra were collected using a 120 
Thermo Nicolet Nexus 870 spectrometer (Waltham, MA, USA) as the average of 32 scans 121 
with a wavenumber resolution of 4 cm-1 in the 600-4000 cm-1 range. As a control, unmodified 122 
MMCF was compared to MMCF-DEAE and spectra were normalised to the common CH2 123 
vibration peak at 2852 cm-1. 124 
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2.6  125 
Ion exchange capacity measurement 126 
The ion exchange capacity was determined using a modified protocol from Karas et al. [14]. 127 
Briefly, 20 sections of 1 cm MMCF-DEAE (dry weight 164 ± 5  mg) were regenerated in 1 128 
M NaOH (40 mL) for 30 minutes prior to a 1 hour step in 1 N HCl (50 mL). After two MilliQ 129 
wash steps (30 minutes each), the MMCF-DEAE segments were placed overnight in 0.1 M 130 
NaNO3 (40 mL) solution under agitation to displace Cl- ions from the modified membrane 131 
into the supernatant. Mohr’s titration was used to titrate the Cl- in solution with 0.1 M AgNO3 132 
and to determine the ion exchange capacity of the membrane. 0.25 M K2CrO4 (1 mL) was 133 
used to indicate when all the Cl- had been exhausted from the supernatant.  134 
Experiments were repeated in triplicate with unmodified MMCF used as a control.  135 
2.7  136 
Adsorption isotherm of BSA onto the membrane  137 
Stock solutions of BSA at concentrations 0.25, 0.5, 1, 2, 3, 5 and 10 mg/mL were prepared in 138 
20 mM Tris-HCl pH 7.2 buffer to determine the adsorption behaviour of protein onto the 139 
membrane. 140 
4 sections of 1 cm MMCF-DEAE (dry weight 33 ± 1 mg) were left for 48 hours under 141 
agitation in 5 mL protein solution to reach equilibrium. To remove unbound protein from the 142 
membrane surface, the supernatant was replaced with 3 mL of buffer and the membrane was 143 
centrifuged at 5000g for 12 minutes. Both supernatants were then combined and a Bradford 144 
assay was used following the protocol provided by the supplier. Measurements of the 145 
remaining BSA in the supernatant were performed at UV 595 nm using a BMG Labtech 146 
SPECTROstar Nano (Allmendgruen, Germany). The amount of protein bound onto the 147 
MMCFs was determined by mass balance and, all experiments were repeated in triplicate. 148 
2.8  149 
Time course binding studies 150 
4 sections of 1 cm MMCF-DEAE membranes were immersed in 1 mg/mL BSA in Tris-HCl 151 
pH 7.2 (5 mL) and were used to determine the binding of BSA onto the membrane as a 152 
function of time. 50 μL samples were taken at t = 0, 0.5, 1, 2, 3, 6, 8, 12, 16, 24, 32 and 48 153 
hours and quantified using a Bradford assay. 154 
Experiments were repeated in triplicate and unmodified MMCF was used as a control. 155 
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2.9  156 
Column fabrication 157 
Extruded membranes were encased in 8 mm FEP tubing (Kinesis Ltd, St. Neots, UK) using 158 
epoxy glue (Araldite®, Cleveland, OH, USA), trimmed to 20 cm in length and fitted with 159 
Upchurch 1/4 inch HPLC connectors to be attached to an ÄKTA FPLC system (GE 160 
Healthcare Life Sciences, Uppsala, Sweden) as described by Mandal et al. [10]. Fig. 2 shows 161 
a schematic representation of the MMCF column module and a SEM image of an MMCF 162 
cross-section.  163 
2.10  164 
Equilibrium binding studies in flow operation 165 
BSA solutions of 1, 5, 10, 20 and 40 mg/mL in 20 mM Tris-HCl pH 7.2 (running buffer) 166 
were loaded to saturation onto the membrane to determine the binding profile of MMCF-167 
DEAE under flow (dynamic) condition. The flowrate was chosen to be 1 mL/min (~ 56.6 168 
CV/h), flowing through the lumen of the membrane. Elution was performed with a step 169 
gradient of 1 M NaCl in running buffer. 170 
 Eqs. (1) was used to calculate the mass of BSA eluted at increasing loading concentration.  171 
𝑀𝑀𝑀𝑀𝑀𝑀𝑀𝑀 𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒 (𝑚𝑚𝑚𝑚) = 𝐶𝐶𝑖𝑖𝑖𝑖𝑖𝑖 (𝑚𝑚𝑚𝑚 𝑚𝑚𝐿𝐿−1×𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸 𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴 (𝑚𝑚𝐴𝐴 𝑈𝑈 𝑚𝑚𝐿𝐿))
100% 𝑆𝑆𝐴𝐴𝐸𝐸𝐸𝐸𝐴𝐴𝐴𝐴𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸 ℎ𝐴𝐴𝐸𝐸𝑚𝑚ℎ𝐸𝐸 (𝑚𝑚𝐴𝐴 𝑈𝑈)       (1) 172 
Where Cinj is the concentration of protein used at injection. 173 
The data was fitted to a Langmuir isotherm adsorption model, described according to Eqs. (2) 174 
derived from adsorption-desorption kinetics: 175 q = qmax αCinj1+αCinj  (2) 176 
With q being the mass bound at all Cinj, qmax the equilibrium binding capacity and α the 177 
Langmuir adsorption constant.  178 
2.11  179 
Effect of pH and flowrate on binding 180 
Frontal analysis experiments using BSA were conducted from pH 6.2 to pH 9.2 to determine 181 
pH dependency of the membrane in flow condition. A 20 mM Tris-HCl running buffer was 182 
used and samples were eluted in running buffer containing 1 M NaCl.  183 
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The column was equilibrated for 5 CV at a flowrate of 1 mL/min, then continuously loaded 184 
through the lumen of the membrane with BSA (10 mg/mL) until 100% column saturation as 185 
determined by UV absorbance measurements at 280 nm. The column was washed with 186 
running buffer for 15 CV followed with a step elution over 10 CV. The column was re-187 
equilibrated for 10 CV between each run.  188 
Experiments were repeated in triplicate and the mass of BSA eluted was calculated using 189 
Eqs. (1). 190 
The effect of flowrate on binding was determined using 100 μL pulse injections of 191 
BSA (5 mg/mL) onto MMCF-DEAE. The capture (%) was calculated using Eqs. (3): 192 
𝐶𝐶𝑀𝑀𝐶𝐶𝑒𝑒𝑒𝑒𝐶𝐶𝑒𝑒 (%) =  𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸 𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴 (𝑚𝑚𝐴𝐴 𝑈𝑈 𝑚𝑚𝐿𝐿)
𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸 𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴 (𝑚𝑚𝐴𝐴 𝑈𝑈 𝑚𝑚𝐿𝐿)+𝐹𝐹𝐸𝐸𝐸𝐸𝐹𝐹𝐸𝐸ℎ𝐴𝐴𝐸𝐸𝐸𝐸𝑚𝑚ℎ 𝐴𝐴𝐴𝐴𝐴𝐴𝐴𝐴 (𝑚𝑚𝐴𝐴 𝑈𝑈 𝑚𝑚𝐿𝐿) × 100    (3) 193 
Flowrates between 0.1 mL/min and 10 mL/min were tested to keep the pressure drop below ~ 194 
1.5 MPa which is the limiting upper pressure for the column adaptors. 195 
2.12  196 
Lysozyme and BSA separation 197 
A subtractive separation of BSA from lysozyme was tested on MMCF-DEAE using 5 mg/mL 198 
lysozyme and 5 mg/mL BSA loaded through the membrane lumen at 1 mL/min until 100% 199 
column saturation. 1 mL fractions of the flowthrough and elution were collected to assess 200 
peak purity using sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE).  201 
 Fractions (diluted tenfold) were loaded onto NuPAGE Novex 4-12% Bis-Tris pre-cast gels 202 
(Invitrogen, Paisley, UK), per the manufacturer’s instructions. Novex Sharp pre-stained 203 
protein standards (Invitrogen, Paisley, UK) were used as molecular weight (MW) markers. 204 
The XCell SureLock Mini-Cell electrophoresis system (Invitrogen, Paisley, UK) was used at 205 
200 V for 35 min with MES SDS running buffer. Coomassie staining was performed using 206 
SimplyBlue SafeStain (Invitrogen, Paisley, UK) following the manufacturer’s protocol.  207 
Experiments were repeated on an unmodified MMCF as a control to determine the presence 208 
of non-specific protein binding to the membrane matrix (see supplementary materials). 209 
2.13  210 
Herring sperm DNA and BSA separation 211 
The ability to separate two anionic molecules was tested using 100 μL injections of BSA (5 212 
mg/mL) and herring sperm DNA (0.25 mg/mL) onto a 20 cm MMCF-DEAE column. A two-213 
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step elution at 0.25 M NaCl and 1 M NaCl was used to separate BSA from DNA. UV 214 
measurements were performed at 254 nm and 20 mM Tris-HCl pH 7.2 was used as the 215 
running buffer at 1 mL/min. 216 
To assess the purity of the elution peaks, the elution fractions were injected onto a 217 
commercial Mono Q 5/50 GL high-resolution Tricorn column (GE Healthcare Life Sciences, 218 
Uppsala, Sweden) following the protocol described in the supplementary materials. 219 
3.  220 
Results and Discussions 221 
3.1  222 
Surface characterisation of MMCFs: Nitrogen adsorption, mercury porosimetry and 223 
FTIR results. 224 
Nitrogen adsorption onto an MMCF sample exhibited a type III isotherm [15] as shown in 225 
Fig. 3A and the BET surface area was calculated to be 8.95 m2/g. The total pore area of 8.6 226 
m²/g obtained from mercury porosimetry was found to agree well with N2 adsorption results 227 
and, a bimodal pore size distribution (PSD) centred at 1000 nm and 100 000 nm in diameter 228 
(see Fig. 3B) was observed. Fig. 2A suggests that, the larger “pores” corresponded to the 229 
central capillaries, defects and macrovoids whereas the pores between 150 nm and 3000 nm 230 
were representative of the PSD within the membrane film. 231 
FTIR spectra of unmodified MMCF and MMCF-DEAE revealed the presence of two 232 
additional peaks at 1578 cm-1 and 1547 cm-1 for MMCF-DEAE (see Fig. 4). These 233 
correspond to in-plane vibration of a triazine [16] and secondary amine N-H bend [17] 234 
respectively. This indicates that both triazine and DEAE were successfully coupled to the 235 
membrane. 236 
3.2  237 
Characterisation of MMCF-DEAE in static conditions: ion exchange capacity and 238 
protein binding isotherm. 239 
The ion exchange capacity of the modified membrane was found to be 195 ± 21 μmol Cl- 240 
/mL, twice the reported value of McCreath et al [13] and comparable to commercial 241 
exchangers (0.11 to 0.16 mmol Cl- /mL medium for DEAE Sepharose Fast Flow [18] and 242 
0.29 to 0.35 mmol Cl- /mL medium for GE Capto DEAE [19]). 243 
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Static binding data fit the Langmuir model well (R2 = 0.98), suggesting monolayer binding of 244 
protein to active sites (see Fig. 5A). The equilibrium binding capacity was measured to be 245 
qmax = 12.4 mg of BSA/mL of adsorbent, similar to the value reported in McCreath et al. of 246 
9.7 mg/mL adsorbent for human serum albumin (HSA) onto perfluoropolymers [13] but more 247 
than an order of magnitude lower than that achieved with commercial membranes [20].   248 
The binding of BSA onto MMCF-DEAE was found to increase linearly during the first 8 249 
hours (see Fig. 6) prior to reaching a plateau at the 12 hour mark due to binding site 250 
saturation. After 24 hours, a maximum binding was reached of 10 mg BSA/mL adsorbent, in-251 
line with the previously observed maximum binding of 10 mg BSA/mL adsorbent at 1 mg 252 
BSA/mL loading (Fig. 5A).  253 
3.3  254 
Performance of MMCF-DEAE under flow conditions: dynamic protein binding capacity 255 
and the effect of pH and flowrate on binding 256 
By loading a 20 cm MMCF-DEAE column with BSA at varying concentrations from 1 257 
mg/mL to 40 mg/mL, an equilibrium dynamic binding profile was obtained and fitted with a 258 
Langmuir equation (see Fig. 5B). The Langmuir model was found to fit the data well (R2 = 259 
0.99) but showed a 30% binding reduction compared to the equilibrium binding capacity 260 
(EBC) obtained under static condition, 8.2 mg BSA/mL adsorber compared to 12.4 mg 261 
BSA/mL adsorber. This has been observed previously [13] and was most likely a result of the 262 
larger mass transfer resistance present in small pores: under flow conditions, some binding 263 
sites were inaccessible to proteins due to the shorter residence times available for the analytes 264 
to diffuse into the membrane matrix. 265 
The effect of pH on binding under flow condition is shown in Fig. 7. As the pH was 266 
increased from pH 6.2 to 9.2, a sharper breakthrough curve (Fig. 7A) during the loading step 267 
was obtained indicating that less mass was bound to the column. This was verified in the 268 
elution step (Fig. 7B) where, the largest elution area was obtained at pH 6.2 corresponding to 269 
a binding of 7.7 mg BSA/mL adsorbent. Further increase in pH resulted in diminished 270 
binding and, at pH 9.2 the elution peak was below detection limit (Fig. 7C). This behaviour 271 
was in-line with what was expected from a weak anion exchanger and the known pKa value 272 
of the tertiary amine group of DEAE ~ 7.1 [21].  At pH > pKa, the protonation of the binding 273 
site was diminished and loss of charge occurred.  274 
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The breakthrough curves at all pHs had a characteristic S-shape corresponding to non-ideal 275 
protein breakthrough. The elution peaks of Fig. 7B show an asymmetrical elution profile with 276 
a long tail (greater than 5 CV) which would suggest that long diffusion times are needed to 277 
elute analytes trapped within the smaller pores of the matrix and within the membrane dead 278 
volume. It is likely that this non-ideality in flow was a result of the non-uniform pore size 279 
within the membrane (see Fig. 3B) and channelling down the membrane bore which have 280 
been shown to increase peak broadening [22]. The pore size distribution introduces a range of 281 
different solute path length and a varying diffusion rate (eddy diffusion) from the stationary 282 
phase to the mobile phase resulting in band broadening [23].  283 
The effect of flowrate on binding was determined using 100 μL injections of BSA (5 mg/mL) 284 
applied onto an MMCF-DEAE column at flowrates ranging from 0.1 mL/min to 10 mL/min 285 
(superficial velocities between 330 –33 000 cm/h through the MMCF lumen). Fig. 8 shows 286 
that increasing the flowrate led to an increase in flowthrough in the loading stage and a 287 
decrease in mass eluted. The capture decreased from 90% at 0.1 mL/min to 63% at 10 288 
mL/min with a sharper drop between 0.1 mL/min and 1 mL/min (Fig. 8C). Increasing the 289 
flowrate above 1 mL/min did not significantly reduce the capture of BSA but introduced peak 290 
broadening. Although membranes typically have flowrate independent binding [24], this 291 
result was not surprising on account of the flow operation chosen. By flowing the protein 292 
mixture in the axial direction, through the membrane lumen, instead of as a radial 293 
transmembrane flow, radial mass transport to the membrane was slow (the Reynolds number 294 
is <<1) and, at high flowrates, binding was reduced due to the decreased residence time 295 
between the mobile phase and stationary phase. 296 
3.4  297 
 Proof-of-concept separations of cationic-anionic and anionic-anionic protein mixtures 298 
using MMCF-DEAE 299 
 The separation of BSA from a lysozyme containing mixture is shown in Fig. 9. It can be 300 
seen that BSA was successfully recovered at high purity as determined by SDS-PAGE 301 
analysis of the elution (Fig. 9B). A faint lysozyme band below the limit of quantification was 302 
observed in the elution suggesting non-specific protein binding. From the control experiment 303 
using unmodified MMCF (see supplementary materials), it is likely that the non-specific 304 
lysozyme was bound to the MMCF backbone and was estimated to be ~ 0.2 mg of 305 
lysozyme/mL of adsorber. Therefore, with the same amount of non-specific binding, a purity 306 
greater than 97% BSA (on a weight basis) was obtained using MMCF-DEAE. The high 307 
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molecular weight species observed in Fig. 9B were neglected in this analysis and most likely 308 
corresponded to dimers and trimers of BSA which have been found to persist even under 309 
denaturing conditions [25].  310 
The separation of two anionic molecules, fish sperm DNA and BSA, onto an MMCF-DEAE 311 
column was tested using a two-step NaCl elution. As can be observed in Fig. 10C, two 312 
elution peaks were obtained. From the controls, Fig. 10A and Fig. 10B, the first elution 313 
corresponded to a BSA dominant peak and that the second elution was DNA dominant. 314 
Further analysis of the fractions collected with a commercial Mono Q 5/50 GL high-315 
resolution Tricorn column (see supplementary materials) indicated that the first peak was 316 
pure BSA and the second elution peak was 81% herring sperm DNA with a 19% BSA 317 
contamination. The detection limit of herring sperm DNA was estimated to be ~ 16 ng of 318 
DNA (see supplementary materials), of similar order of magnitude with the regulatory 319 
requirements of less than 10 ng of genomic DNA per therapeutic dose [26].  320 
The mass of BSA recovered in the first elution peak was 0.38 mg of BSA corresponding to a 321 
77% capture. The low capture of BSA could be improved by loading the column at a lower 322 
flowrate, using longer MMCF columns, increasing the salt concentration in the first elution or 323 
reducing the injected protein concentrations.  324 
4.  325 
Conclusions 326 
In this study, the versatility of MMCFs was demonstrated by successful modification of the 327 
matrix with a new DEAE chemistry for protein chromatography. A simple two-step chemical 328 
modification resulted in a weak anion exchanger, as verified by FTIR analysis. 329 
Characterisation of the membrane showed an ion exchange capacity of 195 ± 21 μmol Cl- 330 
/mL of adsorber, significantly higher than that reported in previous studies and comparable to 331 
commercial exchangers. However, the binding capacity of MMCF-DEAE of 12.4 mg 332 
BSA/mL of adsorber was found to be significantly lower than that of commercial columns. 333 
This indicates that the binding behaviour will have to be improved for any preparative use to 334 
be achieved. Increasing the number of capillaries within the membrane film or improving the 335 
chemical modification used could result in improved binding. 336 
The proof-of-concept separation of BSA from lysozyme revealed that recovery of BSA at 337 
more than 97% purity could easily be achieved. The more complex separation of BSA and 338 
herring sperm DNA demonstrated future potential of resolving two negatively charged 339 
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compounds using this system. 77% of the BSA injected was recovered free of detectable 340 
impurity despite the large DNA load present in the feed mixture.. 341 
These results suggest that with proper optimisation, MMCFs could be used as low-cost 342 
residual DNA clearance devices. 343 
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6. Figure captions 460 
Fig. 1: Chemical route to modify MMCFs into weak anion exchangers using DEAE as the chemical 461 
ligand. Coupling of cyanuric chloride to the membrane was performed and maintained in ice cold 462 
condition until addition of DEAE. 463 
Fig. 2: (A) SEM image of an MMCF cross section taken at the Cambridge Advanced Imaging Centre 464 
(CAIC) at an acceleration voltage of 5.0 kV using FEI Verios 460. Membranes were freeze dried with 465 
liquid nitrogen in a Quorum K775X freeze dryer (Laughton, UK), fractured to obtain clean edges and 466 
gold coated. The average capillary bore diameter was calculated assuming a circular cross-section of 467 
same area using Image J and found to be 351±42 μm. (B) Cross-sectional representation of an MMCF 468 
column module. (C) Schematic representation of an MMCF column encased in a FEP 8 mm tube 469 
fitted with PTFE adaptors.  470 
Fig. 3: (A) Nitrogen adsorption isotherm at 77.4 K of MMCF membrane sample of mass 0.09 g.(B) 471 
Mercury porosimetry pore size distribution of a sample of mass 0.36 g. Smaller pores were attributed 472 
to the pores within the matrix of the membrane whereas the larger apparent pores corresponded to the 473 
capillary bores, macrovoids and other membrane defects. 474 
Fig. 4: FTIR spectra of unmodified and DEAE modified MMCFs normalised to the common CH2 475 
vibrational peak at 2852 cm-1 and offset vertically. Triazine in-plane ring vibrations (1578 cm-1) and 476 
the secondary N-H amine bond (1547 cm-1) of DEAE coupled to the MMCF are shown in bold. 477 
Fig. 5: (A) Static adsorption isotherm of BSA onto MMCF-DEAE. (B) Adsorption isotherm of BSA 478 
on MMCF-DEAE in flow (dynamic) condition. Langmuir fit for (A) qmax = 12.4 mg/mL adsorbent 479 
and α = 0.36. R2 = 0.98.  Langmuir fit for (B) qmax = 8.2 mg/mL adsorbent and alpha = 0.34. R2 = 480 
0.99. Experiments were repeated in triplicate and the standard deviation is shown. The binding 481 
reported was normalised to the column volume of 1.06 mL. 482 
Fig. 6: (A) Time course experiment measuring the mass of BSA bound onto an MMCF-DEAE 483 
membrane with an initial loading solution of 1 mg/mL BSA solution in Tris-HCl. (B) First 8 hours of 484 
the loading. A linear fit was performed and found to agree well with experimental data, R2 = 0.98. 485 
Experiments were repeated in triplicate and the standard deviation is shown.  486 
Fig. 7: Effect of buffer pH on the binding of BSA onto an MMCF-DEAE column. (A) Breakthrough 487 
curves during continuous loading of BSA (10 mg/mL). (B) Elution profile of the bound protein. (C) 488 
Mass of BSA eluted normalised to column volume. Experiments were repeated in triplicate and the 489 
standard deviation is reported.  490 
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Fig. 8: The effect of flowrate on the binding of BSA onto an MMCF-DEAE column. Experiments 491 
were repeated in triplicate at flowrates between 0.1 mL/min and 10 mL/min. Only representative 492 
chromatograms are shown in (A) and (B). (A) corresponds to the sample loading flowthrough and (B) 493 
to the associated elution step. (C) shows the captured amount of BSA in the elution peak relative to 494 
the injected amount of BSA (0.5 mg). The standard deviation is reported.  495 
Fig. 9: (A) Frontal loading of BSA (5 mg/mL) and lysozyme (5 mg/mL). The running buffer was 20 496 
mM Tris-HCl at pH 7.2 and elution was done using 1M NaCl in running buffer. The experiment was 497 
repeated in triplicate and fractions were collected for SDS-PAGE purity assessment. (B) SDS-PAGE 498 
gel of the fractions collected tenfold diluted. Lanes M on either side of the gel correspond to the 499 
molecular weight markers. Lane A is the pure lysozyme control (0.1 mg/mL), lane B the BSA control 500 
(0.1 mg/mL) and lane AB is a mixture of both. Lanes 1 and 2 are fractions collected during the load 501 
step. Lane 3 has a sample of the wash step and lanes 4-7 correspond to the elution of bound protein.  502 
Fig. 10: 100 μL injection of proteins onto an MMCF-DEAE column at a flowrate of 1 mL/min. A 503 
two-step elution is specified at 0.25 M NaCl and 1 M NaCL. (A) BSA injection (5 mg/mL) (B) 504 
Injection of herring sperm DNA (0.25 mg/mL), (C) Mixture of BSA (5 mg/mL) and fish DNA (0.25 505 
mg/mL). Experiments were repeated in triplicate. UV measurements were made at a wavelength of 506 
254 nm. 507 
